Works by Poulsen, Hans Skovgaard


Results: 52
    1
    2
    3

    Gonadal Status in Male Survivors following Childhood Brain Tumors.

    Published in:
    Journal of Clinical Endocrinology & Metabolism, 2001, v. 86, n. 6, p. 2446, doi. 10.1210/jcem.86.6.7544
    By:
    • SCHMIEGELOW, MARIANNE;
    • LASSEN, SØREN;
    • POULSEN, HANS SKOVGAARD;
    • SCHMIEGELOW, KJELD;
    • HERTZ, HENRIK;
    • ANDERSSON, ANNA-MARIA;
    • SKAKKEBÆK, NIELS E.;
    • MULLER, JØRN
    Publication type:
    Article
    4
    5
    6
    7

    Actionable alterations in glioblastoma: Insights from the implementation of genomic profiling as the standard of care from 2016 to 2023.

    Published in:
    Neuro-Oncology Practice, 2025, v. 12, n. 1, p. 34, doi. 10.1093/nop/npae082
    By:
    • Fougner, Vincent;
    • Urup, Thomas;
    • Poulsen, Hans Skovgaard;
    • Grunnet, Kirsten;
    • Westmose, Christina Yde;
    • Melchior, Linea Cecilie;
    • Larsen, Karen Bonde;
    • Højgaard, Martin;
    • Spanggaard, Iben;
    • Belcaid, Laila;
    • Rohrberg, Kristoffer Staal;
    • Lassen, Ulrik;
    • Hasselbalch, Benedikte;
    • Nørøxe, Dorte Schou
    Publication type:
    Article
    8

    Postoperative neoadjuvant temozolomide before radiotherapy versus standard radiotherapy in patients 60 years or younger with anaplastic astrocytoma or glioblastoma: a randomized trial.

    Published in:
    Acta Oncologica, 2017, v. 56, n. 12, p. 1776, doi. 10.1080/0284186X.2017.1332780
    By:
    • Malmström, Annika;
    • Poulsen, Hans Skovgaard;
    • Grønberg, Bjørn Henning;
    • Stragliotto, Giuseppe;
    • Hansen, Steinbjørn;
    • Asklund, Thomas;
    • Holmlund, Birgitta;
    • Łysiak, Małgorzata;
    • Dowsett, Joseph;
    • Kristensen, Bjarne Winther;
    • Söderkvist, Peter;
    • Rosell, Johan;
    • Henriksson, Roger
    Publication type:
    Article
    9
    10

    Neoadjuvant bevacizumab and irinotecan versus bevacizumab and temozolomide followed by concomitant chemoradiotherapy in newly diagnosed glioblastoma multiforme: A randomized phase II study.

    Published in:
    Acta Oncologica, 2014, v. 53, n. 7, p. 939, doi. 10.3109/0284186X.2013.879607
    By:
    • Hofland, Kenneth F.;
    • Hansen, Steinbjørn;
    • Sorensen, Morten;
    • Engelholm, Silke;
    • Schultz, Henrik P.;
    • Muhic, Aida;
    • Grunnet, Kirsten;
    • Ask, Anders;
    • Costa, Junia C.;
    • Kristiansen, Charlotte;
    • Thomsen, Carsten;
    • Poulsen, Hans Skovgaard;
    • Lassen, Ulrik
    Publication type:
    Article
    11
    12
    13
    14
    15

    Added prognostic value of DCE blood volume imaging in patients with suspected recurrent or residual glioblastoma—A hybrid [<sup>18</sup>F]FET PET/MRI study.

    Published in:
    Neuro-Oncology Advances, 2024, v. 6, n. 1, p. 1, doi. 10.1093/noajnl/vdae196
    By:
    • Henriksen, Otto Mølby;
    • Muhic, Aida;
    • Lundemann, Michael Juncker;
    • Larsson, Henrik Bo Wiberg;
    • Lindberg, Ulrich;
    • Andersen, Thomas Lund;
    • Hasselbalch, Benedikte;
    • Møller, Søren;
    • Marner, Lisbeth;
    • Madsen, Karine;
    • Larsen, Vibeke Andrée;
    • Poulsen, Hans Skovgaard;
    • Hansen, Adam Espe;
    • Law, Ian
    Publication type:
    Article
    16

    Magnetic resonance imaging and o-(2-[<sup>18</sup>F]fluoroethyl)-l-tyrosine positron emission tomography for early response assessment of nivolumab and bevacizumab in patients with recurrent high-grade astrocytic glioma.

    Published in:
    Neuro-Oncology Advances, 2024, v. 6, n. 1, p. 1, doi. 10.1093/noajnl/vdae178
    By:
    • Henriksen, Otto Mølby;
    • Maarup, Simone;
    • Hasselbalch, Benedikte;
    • Poulsen, Hans Skovgaard;
    • Christensen, Ib Jarle;
    • Madsen, Karine;
    • Larsen, Vibeke Andrée;
    • Lassen, Ulrik;
    • Law, Ian
    Publication type:
    Article
    17
    18
    19
    20

    Inhibition of Notch signaling alters the phenotype of orthotopic tumors formed from glioblastoma multiforme neurosphere cells but does not hamper intracranial tumor growth regardless of endogene Notch pathway signature.

    Published in:
    Cancer Biology & Therapy, 2014, v. 15, n. 7, p. 862, doi. 10.4161/cbt.28876
    By:
    • Kristoffersen, Karina;
    • Kjølhede Nedergaard, Mette;
    • Villingshøj, Mette;
    • Borup, Rehannah;
    • Broholm, Helle;
    • Kjær, Andreas;
    • Skovgaard Poulsen, Hans;
    • Stockhausen, Marie-Thérése
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30

    Perspective: targeting VEGF-A and YKL-40 in glioblastoma – matter matters.

    Published in:
    Cell Cycle, 2021, v. 20, n. 7, p. 702, doi. 10.1080/15384101.2021.1901037
    By:
    • Holst, Camilla Bjørnbak;
    • Pedersen, Henriette;
    • Obara, Elisabeth Anne Adanma;
    • Vitting-Seerup, Kristoffer;
    • Jensen, Kamilla Ellermann;
    • Skjøth-Rasmussen, Jane;
    • Lund, Eva Løbner;
    • Poulsen, Hans Skovgaard;
    • Johansen, Julia Sidenius;
    • Hamerlik, Petra
    Publication type:
    Article
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40

    THE AUTHORS AND DR. CARDIS REPLY.

    Published in:
    American Journal of Epidemiology, 2004, v. 160, n. 9, p. 924, doi. 10.1093/aje/kwh293
    By:
    • Christensen, Helle Collat;
    • Schüz, Joachim;
    • Kosteljanetz, Michael;
    • Poulsen, Hans Skovgaard;
    • Thomsen, Jens;
    • Cardis, Elisabeth;
    • Johansen, Christoffer
    Publication type:
    Article
    41

    Cellular Telephone Use and Risk of Acoustic Neuroma.

    Published in:
    American Journal of Epidemiology, 2004, v. 159, n. 3, p. 277, doi. 10.1093/aje/kwh032
    By:
    • Christensen, Helle Collatz;
    • Schüz, Joachim;
    • Kosteljanetz, Michael;
    • Poulsen, Hans Skovgaard;
    • Thomsen, Jens;
    • Johansen, Christoffer
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48
    49
    50